|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Affecting the fetuin-A and SIRT1 levels introduces a new known mechanism of probiotic action in diabetes management.
|
30675190 |
2019 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
<b>Conclusion:</b> Lower fetuin-A levels are associated with an increased risk of all-cause mortality independent of diabetes and inflammation in dialysis patients, and there may be a dose-response relationship between them.
|
31417425 |
2019 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
As a multifunctional protein, fetuin-A has positive effects on health such as calcification, cardiovascular diseases and tumor development processes with various mechanisms, whereas it plays a negative role in the processes of obesity, diabetes and fatty liver disease.
|
31232084 |
2019 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
In conclusion, although there is mechanistic evidence for an effect of fetuin-A on insulin sensitivity and secretion, this study does not support a strong, relevant relationship between circulating fetuin-A and diabetes risk in the general population.
|
29523632 |
2018 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Fetuin-A levels increased in association with diabetes in SAT but not in circulation in the obese subjects.
|
30579336 |
2018 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Serum fetuin A levels in T1D patients (mean 0.267 ± 0.043 g/L) did not correlate with age, diabetes duration, gender, body mass index (BMI), glycated hemoglobin, serum lipid levels, blood pressure, celiac or thyroid disease, nephropathy, or retinopathy.
|
29207397 |
2018 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Fetuin-A is a liver-derived circulating protein that is associated with insulin resistance and diabetes.
|
28643299 |
2018 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Participants with diabetes and PAD had lower fetuin-A levels than non-PAD diabetic patients.
|
27899247 |
2017 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
However, it remains unclear whether the association between high levels of fetuin-A and diabetes can be attributed to nonalcoholic fatty liver disease.
|
27856445 |
2017 |
|
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Plasma fetuin-A is associated with type 2 diabetes, and AHSG, the gene encoding fetuin-A, has been identified as a susceptibility locus for diabetes and metabolic syndrome.
|
28379451 |
2017 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Therefore, we examined the effects of 6-month AEX+WL on plasma fetuin-A levels (36-48 hours after the last bout of exercise), aerobic capacity (VO<sub>2max</sub>), body composition, glucose tolerance, and insulin sensitivity (M) in 16 sedentary, overweight-obese older men (age = 60 ± 2 years, BMI = 31 ± 1 kg/m<sup>2</sup>) with no history of cardiovascular disease or diabetes.
|
28770230 |
2017 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Other risk factors, including inflammation and diabetes, might lead to lower fetuin-A levels, and/or modify the effect of low fetuin-A on mortality in end-stage renal disease patients.
|
20605840 |
2011 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
In a logistic regression model (N= 101), fetuin-A was significantly (P < 0.05) associated with the presence of carotid plaques independently of age, CVD, diabetes, S-albumin, gender, and inflammation.
|
15882283 |
2005 |